Covid Third Wave: The evolving nature of the corona virus there is a need for new vaccines and therapeutics to halt the surge, which throws up a new business opportunity for the indian pharma industry. what is planned?
Ramping up production capacities and meeting supply demands of new COVID-19 vaccines and therapeutics is likely to be the key focus for pharma companies in 2022.